Stacey Liekweg

President chez Immunovalent Therapeutics, Inc.

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Eric C. Leuthardt	M	-	Immunovalent Therapeutics, Inc. Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO.	-
Robert J. Calcaterra	M	-	Immunovalent Therapeutics, Inc. Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO.	-
Steven George	M	-	Immunovalent Therapeutics, Inc. Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO.	-
Gary Lazar	M	-	Immunovalent Therapeutics, Inc. Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO.	-
John Hardin	M	-	Caelivascular, Inc. Caelivascular, Inc. Medical SpecialtiesHealth Technology CaeliVascular, Inc. is a medical company that specializes in developing innovative catheters for vascular surgery. The company is based in St. Louis, MO. The company's focus is on transforming the treatment of deep vein thrombosis and pulmonary embolism. The CEO of the company is John Hardin.	-